Small interfering RNA (siRNA)-mediated silencing of HDAC2 inhibited HCC growth in vitro (accompanied by the deregulation of HDAC-regulated genes, such as p27, p53, BCL-2, or PPAR-γ) and in vivo in mouse xenograft models [19]. This evidence concerns the gene TP53 and hepatocellular carcinoma.